FDA Drug recall D-0129-2018
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharma…
- FDA Drug
- Class II
- terminated
- Published 2017-12-27
On 2017-12-27 the FDA classified a Class II recall of Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharma… by Premier Pharmacy Labs, citing stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0129-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-08-10 |
| Published | 2017-12-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Premier Pharmacy Labs |
| Distribution | FL, MD, MI, MN, NC, OH |
Product
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Reason
Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
Identifiers
| code_info | Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0129-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.